Maven Bio's AI-driven platform accelerates biopharma deal analysis, enhancing M&A intelligence and strategic decision-making.
Maven Bio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2023.
Maven Bio's investors include Y Combinator.
Maven Bio is headquartered in Boston, United States.
Maven Bio's AI-driven platform accelerates biopharma deal analysis, enhancing M&A intelligence and strategic decision-making.
Maven Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Maven Bio — Funding & Investors." VCBacked, September 6, 2023, https://www.vcbacked.co/company/maven-bio. Accessed July 25, 2026.
VCBacked. (2023). Maven Bio — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/maven-bio
{{cite web |title=Maven Bio — Funding & Investors |url=https://www.vcbacked.co/company/maven-bio |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated